Repligen Agrees To Acquire Metenova Expanding Repligen's Fluid Management Portfolio, Complements Single-use Bag Offering, Deal Terms Were Not Disclosed
Portfolio Pulse from Benzinga Newsdesk
Repligen has agreed to acquire Metenova, a company that is projected to generate revenues of $24 million to $25 million for fiscal year 2023. The acquisition is expected to contribute approximately $5 million in revenue to Repligen in the fourth quarter of 2023, and $25 million to $27 million in revenue in 2024, with 20%-25% revenue growth in 2025 forward. The acquisition is anticipated to be accretive to Repligen's adjusted gross and operating margins in 2024, and to be accretive to adjusted earnings per share in 2025.
September 26, 2023 | 11:37 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Repligen's acquisition of Metenova is expected to contribute to its revenues and margins from 2023 onwards.
The acquisition of Metenova by Repligen is expected to contribute significantly to its revenues and margins from 2023 onwards. This is likely to have a positive impact on Repligen's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100